CIK 0001422142 · Non-accelerated filer<br>Smaller reporting company
Whitehawk Therapeutics, Inc.
Sign in to watch- Ticker
- WHWK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 611547850
- Phone
- 551-321-2234
- Business address
- 2 HEADQUARTERS PLAZA, EAST BUILDING, 11TH FLOOR, MORRISTOWN, NJ, 07960
- Former names
- Aadi Bioscience, Inc., Aerpio Pharmaceuticals, Inc., ZETA ACQUISITION CORP II
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-10-03 | Desai Neil Executive Chairman | Sale | −16,431 | $4.10 | $67K | 1,621,543 |
| 2023-10-02 | Desai Neil Executive Chairman | Sale | −25,569 | $4.37 | $112K | 1,637,974 |
| 2023-10-02 | Lennon David James Chief Executive Officer | Grant or award · Restricted Stock Units | +32,558 | 32,558 | ||
| 2023-10-02 | Lennon David James Chief Executive Officer | Grant or award · Stock Option (right to buy) | +490,000 | 490,000 | ||
| 2023-09-06 | Desai Neil Executive Chairman | Sale | −7,111 | $5.29 | $38K | 1,663,543 |
| 2023-09-05 | Desai Neil Executive Chairman | Sale | −21,000 | $5.63 | $118K | 1,670,654 |
| 2023-09-01 | Desai Neil Executive Chairman | Sale | −13,889 | $5.97 | $83K | 1,691,654 |
| 2023-08-02 | Desai Neil Executive Chairman | Sale | −19,290 | $5.20 | $100K | 1,705,543 |
| 2023-08-01 | Desai Neil Executive Chairman | Sale | −22,710 | $5.22 | $119K | 1,724,833 |
| 2023-07-06 | Desai Neil Executive Chairman | Sale | −15,829 | $6.27 | $99K | 1,747,543 |
| 2023-07-05 | Desai Neil Executive Chairman | Sale | −16,171 | $6.55 | $106K | 1,763,372 |
| 2023-07-03 | Desai Neil Executive Chairman | Sale | −10,000 | $6.64 | $66K | 1,779,543 |
| 2023-06-15 | Aghazadeh Behzad Director | Grant or award · Stock Option (right to buy) | +28,255 | 28,255 | ||
| 2023-06-15 | Castelein Caley Director | Grant or award · Stock Option (right to buy) | +28,255 | 28,255 | ||
| 2023-06-15 | Maroun Richard E Director | Grant or award · Stock Option (right to buy) | +28,255 | 28,255 | ||
| 2023-06-15 | Reeve Emma Director | Grant or award · Stock Option (right to buy) | +28,255 | 28,255 | ||
| 2023-06-15 | Dalal Anupam Director | Grant or award · Stock Option (right to buy) | +28,255 | 28,255 | ||
| 2023-06-15 | Hehenberger Karin M. Director | Grant or award · Stock Option (right to buy) | +28,255 | 28,255 | ||
| 2023-06-06 | Desai Neil Executive Chairman | Sale | −7,260 | $8.19 | $59K | 1,789,543 |
| 2023-06-05 | Desai Neil Executive Chairman | Sale | −17,315 | $8.11 | $140K | 1,796,803 |
Page 8 of 9 · 171 trades